Inactive Instrument
Pandion Therapeutics, Inc. Share Price
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 31/07/2020 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/04/21 | Tender | Director | 91,738 | 0.3108% | ||
| 01/04/21 | Polaris Growth Management LLC
| Tender | Company | 3,201,422 | 10.8465% | |
| 01/04/21 | Tender | Executive/Senior Manager | 189,780 | 0.6430% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 1.7B | |
| +3.31% | -3.70% | +61.03% | +103.64% | 71.35B | |
| +2.39% | +2.58% | +50.38% | +91.70% | 64.17B | |
| -1.90% | -1.48% | +6.36% | -7.65% | 28.65B | |
| -1.04% | -6.25% | -7.32% | +466.60% | 27.06B | |
| -2.78% | +4.47% | +52.49% | +14.43% | 27.33B | |
| -1.68% | +0.33% | +36.86% | -17.91% | 20.47B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 19.36B | |
| -0.57% | -4.06% | +10.79% | +515.61% | 15.96B | |
| -0.33% | +4.06% | +47.63% | +155.18% | 14.05B | |
| Average | -0.14% | +4.46% | +58.63% | +193.55% | 32.04B | |
| Weighted average by Cap. | +0.69% | +3.31% | +54.85% | +153.47% |
Employees
56
